United States Ophthalmic Drugs Market Report 2016

November 2016 | 120 pages | ID: UE8CB27E9E5EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Ophthalmic Drugs

Revenue, means the sales value of Ophthalmic Drugs

This report studies sales (consumption) of Ophthalmic Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novartis
• Santen Pharmaceutical
• Merck
• Roche Holding AG
• Pfizer
• Allergan
• Valeant
• Regeneron
• Bayer
• Senju
• Akorn

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Prescription Drugs
• OTC Drugs
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Ophthalmic Drugs in each application, can be divided into

• Dry Eye Drugs
• Retinal Drugs
• Anti-inflammatory/allergy/infective Drugs
• Anti-glaucoma Drugs
• Others

Contents

United States Ophthalmic Drugs Market Report 2016

1 OPHTHALMIC DRUGS OVERVIEW

1.1 Product Overview and Scope of Ophthalmic Drugs
1.2 Classification of Ophthalmic Drugs
  1.2.1 Prescription Drugs
  1.2.2 OTC Drugs
  1.2.3 Type III
1.3 Application of Ophthalmic Drugs
  1.3.1 Dry Eye Drugs
  1.3.2 Retinal Drugs
  1.3.3 Anti-inflammatory/allergy/infective Drugs
  1.3.4 Anti-glaucoma Drugs
  1.3.5 Others
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Ophthalmic Drugs (2011-2021)
  1.4.1 United States Ophthalmic Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Ophthalmic Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES OPHTHALMIC DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Ophthalmic Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Ophthalmic Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Ophthalmic Drugs Average Price by Manufactures (2015 and 2016)
2.4 Ophthalmic Drugs Market Competitive Situation and Trends
  2.4.1 Ophthalmic Drugs Market Concentration Rate
  2.4.2 Ophthalmic Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES OPHTHALMIC DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Ophthalmic Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Ophthalmic Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Ophthalmic Drugs Price by Type (2011-2016)
3.4 United States Ophthalmic Drugs Sales Growth Rate by Type (2011-2016)

4 UNITED STATES OPHTHALMIC DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Ophthalmic Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Ophthalmic Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES OPHTHALMIC DRUGS MANUFACTURERS PROFILES/ANALYSIS

5.1 Novartis
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Ophthalmic Drugs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Novartis Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Santen Pharmaceutical
  5.2.2 Ophthalmic Drugs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Santen Pharmaceutical Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Merck
  5.3.2 Ophthalmic Drugs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Merck Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Roche Holding AG
  5.4.2 Ophthalmic Drugs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Roche Holding AG Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Pfizer
  5.5.2 Ophthalmic Drugs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Pfizer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Allergan
  5.6.2 Ophthalmic Drugs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Allergan Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Valeant
  5.7.2 Ophthalmic Drugs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Valeant Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Regeneron
  5.8.2 Ophthalmic Drugs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Regeneron Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Bayer
  5.9.2 Ophthalmic Drugs Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Bayer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Senju
  5.10.2 Ophthalmic Drugs Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Senju Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Akorn

6 OPHTHALMIC DRUGS MANUFACTURING COST ANALYSIS

6.1 Ophthalmic Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Ophthalmic Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Ophthalmic Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Ophthalmic Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES OPHTHALMIC DRUGS MARKET FORECAST (2016-2021)

10.1 United States Ophthalmic Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Ophthalmic Drugs Sales Forecast by Type (2016-2021)
10.3 United States Ophthalmic Drugs Sales Forecast by Application (2016-2021)
10.4 Ophthalmic Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ophthalmic Drugs
Table Classification of Ophthalmic Drugs
Figure United States Sales Market Share of Ophthalmic Drugs by Type in 2015
Figure Prescription Drugs Picture
Figure OTC Drugs Picture
Table Application of Ophthalmic Drugs
Figure United States Sales Market Share of Ophthalmic Drugs by Application in 2015
Figure Dry Eye Drugs Examples
Figure Retinal Drugs Examples
Figure Anti-inflammatory/allergy/infective Drugs Examples
Figure Anti-glaucoma Drugs Examples
Figure Others Examples
Figure United States Ophthalmic Drugs Sales and Growth Rate (2011-2021)
Figure United States Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
Table United States Ophthalmic Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Ophthalmic Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ophthalmic Drugs Sales Share by Manufacturers
Figure 2016 Ophthalmic Drugs Sales Share by Manufacturers
Table United States Ophthalmic Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Ophthalmic Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Ophthalmic Drugs Revenue Share by Manufacturers
Table 2016 United States Ophthalmic Drugs Revenue Share by Manufacturers
Table United States Market Ophthalmic Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Ophthalmic Drugs Average Price of Key Manufacturers in 2015
Figure Ophthalmic Drugs Market Share of Top 3 Manufacturers
Figure Ophthalmic Drugs Market Share of Top 5 Manufacturers
Table United States Ophthalmic Drugs Sales by Type (2011-2016)
Table United States Ophthalmic Drugs Sales Share by Type (2011-2016)
Figure United States Ophthalmic Drugs Sales Market Share by Type in 2015
Table United States Ophthalmic Drugs Revenue and Market Share by Type (2011-2016)
Table United States Ophthalmic Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Ophthalmic Drugs by Type (2011-2016)
Table United States Ophthalmic Drugs Price by Type (2011-2016)
Figure United States Ophthalmic Drugs Sales Growth Rate by Type (2011-2016)
Table United States Ophthalmic Drugs Sales by Application (2011-2016)
Table United States Ophthalmic Drugs Sales Market Share by Application (2011-2016)
Figure United States Ophthalmic Drugs Sales Market Share by Application in 2015
Table United States Ophthalmic Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Ophthalmic Drugs Sales Growth Rate by Application (2011-2016)
Table Novartis Basic Information List
Table Novartis Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Ophthalmic Drugs Sales Market Share (2011-2016)
Table Santen Pharmaceutical Basic Information List
Table Santen Pharmaceutical Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Santen Pharmaceutical Ophthalmic Drugs Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Ophthalmic Drugs Sales Market Share (2011-2016)
Table Roche Holding AG Basic Information List
Table Roche Holding AG Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Holding AG Ophthalmic Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Ophthalmic Drugs Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Ophthalmic Drugs Sales Market Share (2011-2016)
Table Valeant Basic Information List
Table Valeant Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Ophthalmic Drugs Sales Market Share (2011-2016)
Table Regeneron Basic Information List
Table Regeneron Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Regeneron Ophthalmic Drugs Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Ophthalmic Drugs Sales Market Share (2011-2016)
Table Senju Basic Information List
Table Senju Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Senju Ophthalmic Drugs Sales Market Share (2011-2016)
Table Akorn Basic Information List
Table Akorn Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Akorn Ophthalmic Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ophthalmic Drugs
Figure Manufacturing Process Analysis of Ophthalmic Drugs
Figure Ophthalmic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Ophthalmic Drugs Major Manufacturers in 2015
Table Major Buyers of Ophthalmic Drugs
Table Distributors/Traders List
Figure United States Ophthalmic Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Ophthalmic Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Ophthalmic Drugs Production Forecast by Type (2016-2021)
Table United States Ophthalmic Drugs Consumption Forecast by Application (2016-2021)